An Empirical Analysis of Anti-Cancer Drug Lags in South Korea
This study attempts to examine how cancer drug lags in South Korea, along with submission-to-approval and approval-to-reimbursement decision time spans, have evolved over the last decade, from 2013 to 2022. For the same set of cancer drugs, the drug lags observed in South Korea were compared with th...
Saved in:
| Main Authors: | Sung Kyung Lee, Jong Hyuk Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Inquiry: The Journal of Health Care Organization, Provision, and Financing |
| Online Access: | https://doi.org/10.1177/00469580251363855 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of drug pricing drivers under South Korea’s pharmaco-economic evaluation exemption policy (2015–2022)
by: Seung Rae Yu, et al.
Published: (2025-01-01) -
An Empirical Analysis of Technology Transfer of National R&D Projects in South Korea
by: Mi-Sun Kim, et al.
Published: (2015-01-01) -
International comparison of generic competition, prices, and usage trends: South Korea and G20 countries
by: Da Hye Lee, et al.
Published: (2025-05-01) -
Association Between Deforestation and the Incidence of Snakebites in South Korea
by: Seoheui Lee, et al.
Published: (2025-01-01) -
Development and Validation of the Learning Leader Competency Test for University Students in South Korea
by: Eun-Ju Choi, JuSung Jun, Kyung-Hwa Lee
Published: (2024-01-01)